M L Lehman - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Proceedings. AMIA Symposium|February 9, 2002

Physician Order Entry impact on drug turn-around timesM L Lehman, J H Brill, P C Skarulis, et al.

British Journal of Cancer|November 18, 2015

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progressionR Böttcher, D J P Henderson, K Dulla, et al.

Oncogene|January 17, 2017

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortalityB W C Tse, M Volpert, E Ratther, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Proceedings. AMIA Symposium|February 9, 2002

Physician Order Entry impact on drug turn-around timesM L Lehman, J H Brill, P C Skarulis, et al.

British Journal of Cancer|November 18, 2015

Human phosphodiesterase 4D7 (PDE4D7) expression is increased in TMPRSS2-ERG-positive primary prostate cancer and independently adds to a reduced risk of post-surgical disease progressionR Böttcher, D J P Henderson, K Dulla, et al.

Oncogene|January 17, 2017

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortalityB W C Tse, M Volpert, E Ratther, et al.

Pageof 1